Antagonism by the suramin analogue NF279 on human P2X 1 and P2X 7 receptors

By Klapperstuck M.   Buttner C.   Nickel P.   Schmalzing G.   Lambrecht G.   Markwardt F.  

European Journal of Pharmacology, Vol. 387, Iss. 3, 2000-01 ,pp. : 245-252

Elsevier

Access to resources Recommend Favorite

NF279: a novel potent and selective antagonist of P2X receptor-mediated responses

By Damer S.   Niebel B.   Czeche S.   Nickel P.   Ardanuy U.   Schmalzing G.   Rettinger J.   Mutschler E.   Lambrecht G.  

European Journal of Pharmacology, Vol. 350, Iss. 1, 1998-05 ,pp. : 5-6

Elsevier

Access to resources Recommend Favorite

Dissecting Individual Current Components of Co-expressed Human P2X1 and P2X7 Receptors

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 16, 2004-12 ,pp. : 1719-1730

Bentham Science Publishers

Access to resources Recommend Favorite

The novel pyridoxal-5'-phosphate derivative PPNDS potently antagonizes activation of P2X 1 receptors

By Lambrecht G.   Rettinger J.   Baumert H.G.   Czeche S.   Damer S.   Ganso M.   Hildebrandt C.   Niebel B.   Spatz-Kumbel G.   Schmalzing G.   Mutschler E.  

European Journal of Pharmacology, Vol. 387, Iss. 3, 2000-01 ,pp. : 19-21

Elsevier

Access to resources Recommend Favorite

Potent desensitization of human P2X 3 receptors by diadenosine polyphosphates

By McDonald H.A.   Chu K.L.   Bianchi B.R.   McKenna D.G.   Briggs C.A.   Burgard E.C.   Lynch K.J.   Faltynek C.   Cartmell J.   Jarvis M.F.  

European Journal of Pharmacology, Vol. 435, Iss. 2, 2002-01 ,pp. : 135-142

Elsevier

Access to resources Recommend Favorite